Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 74001 - 74025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	MIR455	619556	downregulated	Silver analog results in decreased expression of MIR455 mRNA	9q32	A24215
Silver	Approved Investigational	MIR483	619552	upregulated	Silver analog results in increased expression of MIR483 mRNA	11p15.5	A24215
Silver	Approved Investigational	MIR490	574443	downregulated	Silver analog results in decreased expression of MIR490 mRNA	7q33	A24215
Silver	Approved Investigational	MIR490	574443	downregulated	Silver results in decreased expression of MIR490 mRNA	7q33	A24215
Silver	Approved Investigational	MIR504	574507	downregulated	Silver analog results in decreased expression of MIR504 mRNA	Xq26.3	A24215
Silver	Approved Investigational	MIR504	574507	downregulated	Silver results in decreased expression of MIR504 mRNA	Xq26.3	A24215
Silver	Approved Investigational	MIR514B	100422847	upregulated	Silver results in increased expression of MIR514B mRNA	Xq27.3	A24216
Silver	Approved Investigational	MIR545	664614	upregulated	Silver results in increased expression of MIR545 mRNA	Xq13.2	A24215
Silver	Approved Investigational	MIR548A3	693127	downregulated	Silver analog results in decreased expression of MIR548A3 mRNA	8q22.3	A24215
Silver	Approved Investigational	MIR548C	693129	downregulated	Silver analog results in decreased expression of MIR548C mRNA	12q14.2	A24215
Silver	Approved Investigational	MIR548D1	693130	downregulated	Silver analog results in decreased expression of MIR548D1 mRNA	8q24.13	A24215
Silver	Approved Investigational	MIR551B	693136	downregulated	Silver results in decreased expression of MIR551B mRNA	3q26.2	A24216
Silver	Approved Investigational	MIR559	693144	downregulated	Silver results in decreased expression of MIR559 mRNA	2p21	A24216
Silver	Approved Investigational	MIR566	693151	downregulated	Silver analog results in decreased expression of MIR566 mRNA	3p21.31	A24215
Silver	Approved Investigational	MIR571	693156	downregulated	Silver analog results in decreased expression of MIR571 mRNA	4p16.3	A24215
Silver	Approved Investigational	MIR571	693156	downregulated	Silver results in decreased expression of MIR571 mRNA	4p16.3	A24215
Silver	Approved Investigational	MIR579	693164	downregulated	Silver analog results in decreased expression of MIR579 mRNA	5p13.3	A24215
Silver	Approved Investigational	MIR579	693164	downregulated	Silver results in decreased expression of MIR579 mRNA	5p13.3	A24215
Silver	Approved Investigational	MIR580	693165	downregulated	Silver analog results in decreased expression of MIR580 mRNA	5p13.2	A24215
Silver	Approved Investigational	MIR580	693165	downregulated	Silver results in decreased expression of MIR580 mRNA	5p13.2	A24215
Silver	Approved Investigational	MIR593	693178	upregulated	Silver results in increased expression of MIR593 mRNA	7q32.1	A24216
Silver	Approved Investigational	MIR597	693182	downregulated	Silver analog results in decreased expression of MIR597 mRNA	8p23.1	A24215
Silver	Approved Investigational	MIR597	693182	upregulated	Silver results in increased expression of MIR597 mRNA	8p23.1	A24215
Silver	Approved Investigational	MIR603	693188	upregulated	Silver analog results in increased expression of MIR603 mRNA	10p12.2	A24215
Silver	Approved Investigational	MIR610	693195	downregulated	Silver analog results in decreased expression of MIR610 mRNA	11p14.1	A24215

Displaying entries 74001 - 74025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability